Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10370387 Tricyclic fused thiophene derivatives as JAK inhibitors

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Song Mei0

Wenyu Zhu0

Yun-Long Li0

Date of Patent

August 6, 2019

Patent Application Number

15874140

Date Filed

January 18, 2018

Patent Citations

US Patent 10077277 Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors

0

US Patent 10064866 Treatment of B-cell malignancies by a combination JAK and PI3K inhibitors

0

US Patent 10053465 Pyrrolopyrimidine derivatives as TAM inhibitors

0

Patent Citations Received

US Patent 11992490 Use of JAK1 inhibitors for the treatment of cutaneous lupus erythematosus and Lichen planus (LP)

0

US Patent 11304949 Treatment of hidradenitis suppurativa using JAK inhibitors

US Patent 11851442 Tricyclic fused thiophene derivatives as JAK inhibitors

0

Patent Primary Examiner

Daniel R Carcanague

Patent abstract

The present invention provides tricyclic fused thiophene derivatives, as well as their compositions and methods of use, that modulate the activity of Janus kinase (JAK) and are useful in the treatment of diseases related to the activity of JAK including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10370387 Tricyclic fused thiophene derivatives as JAK inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool